Long-term Extension Trial of Asenapine in Subjects With Schizophrenia (Study P06125)

NCT01142596 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

201

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Asenapine
DRUG: Placebo

Sponsor

Organon and Co

Collaborators

[object Object]